Orchid Pharma launches new antibiotic Cefepime-Enmetazobactam in partnership with Cipla, addressing antimicrobial resistance in India.
Orchid Pharma Limited launches Cefepime-Enmetazobactam, a new antibiotic approved for treating complicated urinary tract infections, hospital-acquired pneumonia, and ventilator-associated pneumonia. The company partners with Cipla Limited to distribute the drug across India. The collaboration aims to address antimicrobial resistance, a growing global health concern, and showcases India's leadership in medical innovation.
July 01, 2024
3 Articles